BRAFV600E mutation as a predictor of thyroid malignancy in indeterminate nodules: A systematic review and meta-analysis
M Jinih, N Foley, O Osho, L Houlihan, AA Toor… - European Journal of …, 2017 - Elsevier
Background Thyroid nodules are usually diagnosed using fine-needle aspiration (FNA). The
sensitivity limitations of FNA result in 10–30% of nodules being classified as “indeterminate” …
sensitivity limitations of FNA result in 10–30% of nodules being classified as “indeterminate” …
Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction
MP Fano, AU Olano, EF Thomas, AO Alday - Endocrinología, Diabetes y …, 2017 - Elsevier
Abstract Introduction The BRAF V600E mutation is the most common genetic change in
papillary thyroid carcinoma and is associated with a poorer clinical course. Usual methods …
papillary thyroid carcinoma and is associated with a poorer clinical course. Usual methods …
Detección inmunohistoquímica de la mutación BRAF V600E en el carcinoma papilar de tiroides. Evaluación frente a la reacción en cadena de la polimerasa en …
MP Fano, AU Olano, EF Thomas, AO Alday - Endocrinología, Diabetes y …, 2017 - Elsevier
Introducción La mutación V600E de BRAF (protooncogén B-Raf) asocia mayor riesgo de
persistencia y recidiva en el carcinoma papilar de tiroides, y puede modificar la cirugía o el …
persistencia y recidiva en el carcinoma papilar de tiroides, y puede modificar la cirugía o el …
Molecular testing of thyroid nodules
L Yip - Endocrine Surgery, 2017 - taylorfrancis.com
Thyroid cancer is one of the few malignancies that are increasing in incidence. Although
early detection may be one reason for the rise, other variables may also be contributing to …
early detection may be one reason for the rise, other variables may also be contributing to …
[PDF][PDF] Endocrinología, Diabetes y Nutrición
A Ramos, L Zapata, P Vera, AJ Betbese, A Pérez - 2017 - researchgate.net
Background and aims: The optimal initial dose of subcutaneous (SC) insulin after
intravenous (IV) infusion is controversial, especially in patients receiving continuous enteral …
intravenous (IV) infusion is controversial, especially in patients receiving continuous enteral …